AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

  • Products Id :- E38302B9-506B-4E28-9ECC-BE2B685B9834
  • |
  • Pages: 63
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

AbbVie Inc.-Strategy, SWOT and Corporate Finance Report


AbbVie Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

AbbVie Inc. (AbbVie or 'the company') is a research-based biopharmaceutical company. It classifies its business into one segment: Pharmaceutical Products. Its pharmaceuticals product portfolio consists mainly of Humira (adalimumab) and products in therapeutic areas of oncology, metabolics/hormone, endocrinology, and virology. The company operates in the US, Canada, Mexico, European Union, Japan, Brazil and other countries. It is headquartered in North Chicago, Illinois.


- Detailed information on AbbVie Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis

- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments

- Intelligence on AbbVie Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about AbbVie Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AbbVie Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess AbbVie Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on AbbVie Inc.'s business structure, strategy and prospects.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Company Snapshot 2

Table of Contents 5

AbbVie Inc.: Company Overview 9

AbbVie Inc.: Overview and Key Facts 9

AbbVie Inc.: Overview 9

AbbVie Inc.: Key Facts 9

AbbVie Inc.: Key Employees 11

AbbVie Inc.: Key Employee Biographies 12

AbbVie Inc.: Major Products and Services 18

AbbVie Inc.: Company History 19

AbbVie Inc.: Management Statement 27

AbbVie Inc.: Locations and Subsidiaries 29

AbbVie Inc.: Key Competitors 31

AbbVie Inc.: Company Analysis 32

AbbVie Inc.: Business Description 32

AbbVie Inc.: SWOT Analysis 34

AbbVie Inc.: SWOT Overview 34

AbbVie Inc.: Strengths 34

AbbVie Inc.: Weaknesses 35

AbbVie Inc.: Opportunities 36

AbbVie Inc.: Threats 38

AbbVie Inc.: Corporate Financial Deals Activity 40

AbbVie Inc.: Financial Deals Overview 40

AbbVie Inc.: Targets and Partners 42

AbbVie Inc.: Top Deals 2014-2018YTD 45

AbbVie Inc.: Advisors 46

AbbVie Inc.: Top Legal Advisors 46

AbbVie Inc.: Top Financial Advisors 46

AbbVie Inc.: Mergers and Acquisitions 47

AbbVie Inc.: Corporate Venturing 48

AbbVie Inc.: Capital Raising 49

AbbVie Inc.: Partnership 50

AbbVie Inc.: Recent Developments 51

AbbVie Inc.: News and Events Summary 51

AbbVie Inc.: Contracts 55

AbbVie Inc.: Corporate Governance 56

AbbVie Inc.: Corporate Social Responsibility 57

AbbVie Inc.: Financial Deals 58

AbbVie Inc.: Financial Performance 58

AbbVie Inc.: Market Developments 58

AbbVie Inc.: Regulatory and Legal Events 59

AbbVie Inc.: Strategy and Operations 60

Appendix 61

Contact Us 61

Methodology 61

About MarketLine 62

List of Figures

Figure 1: AbbVie Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: AbbVie Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: AbbVie Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: AbbVie Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Figure 5: AbbVie Inc.: M&A Activity by Geography (2014-YTD 2018)

Figure 6: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Figure 7:

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

select a license
Single User License
USD 175 INR 12250
Site License
USD 350 INR 24500
Corporate User License
USD 525 INR 36750



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]